Predicting jaw bone risks from bone medications before dental procedures
Part of Bones, joints & muscles, Mouth & dental clinical trials.
This study looks at your risk of developing a rare jaw bone problem from certain bone-strengthening medications before, during, and after a needed dental procedure. Your participation could help find early warning signs and improve prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been taking a bone-strengthening drug (like a bisphosphonate or denosumab) for at least 2 years.
- You are about to have a dental procedure that involves cutting into your mouth or jaw, such as a tooth removal or root canal.
- You do not have any signs of a jaw bone problem (like exposed bone) before the dental procedure.
- You do not have severe health issues like uncontrolled heart, liver, or kidney disease, or a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of medicines (pentoxifylline and tocopherol, a form of vitamin E) to treat damage to the jaw bone caused by bone-strengthening drugs. If you have Stage 2 MRONJ and meet other criteria, this treatment may help heal the bone.
This study follows patients with medication-related osteonecrosis of the jaw (a bone condition often caused by certain cancer or osteoporosis medicines) using imaging scans to understand how the bone changes over time. The goal is to better predict outcomes and improve treatment.
This study looks at people who have jaw bone damage (osteonecrosis) caused by medications. Researchers want to understand what treatments and risk factors are linked to this condition to help improve care.
This study looks at what changes happen in the jawbone in people with osteonecrosis of the jaw (a damaged jawbone area), whether or not they take certain cancer/bone medicines. It may help doctors better understand the condition and how it behaves over time.
This study looks at how a specific jaw problem (osteonecrosis) may happen in people taking bone-strengthening medications. It aims to better understand and manage this side effect.
This study compares two ways to treat a jaw bone problem caused by medications (called MRONJ) when it happens around a dental implant. One option is to keep the implant and treat the bone, the other is to remove the implant. The goal is to see which approach leads to better healing.
Hear when a new Medication-related Osteonecrosis of the Jaw (MRONJ) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.